| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F |
| P698 | PubMed publication ID | 8650125 |
| P50 | author | Philip G. Knight | Q46930651 |
| P2093 | author name string | George L | |
| Wald NJ | |||
| Muttukrishna S | |||
| Densem JW | |||
| P433 | issue | 2 | |
| P921 | main subject | serum marker | Q129938692 |
| P304 | page(s) | 143-153 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Prenatal screening for Down's syndrome using inhibin-A as a serum marker | |
| P478 | volume | 16 |
| Q64053694 | A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a population-based study |
| Q24307781 | Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium |
| Q78171436 | Advance in the study of inhibin, activin and follistatin production in pregnant women |
| Q34140689 | Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing |
| Q34804625 | Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions |
| Q73937660 | Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome |
| Q73138939 | Antenatal screening for Down's syndrome with the quadruple test |
| Q77151494 | Antenatal screening for Down's syndrome: where are we and where next? |
| Q74520558 | Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome |
| Q34307716 | Changes in inhibins and activin secretion in healthy and pathological pregnancies |
| Q79298661 | Combined Sonographic and Biochemical Markers for Down Syndrome Screening |
| Q61848074 | Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker |
| Q57523671 | Down's syndrome screening with nuchal translucency |
| Q71916938 | Down's syndrome screening with nuchal translucency |
| Q34193225 | Down's syndrome screening: a controversial test, with more controversy to come! |
| Q46790146 | Effect of allowing for ethnic group in prenatal screening for Down's syndrome |
| Q77359505 | Effect of fetal gender on first trimester markers and on Down syndrome screening |
| Q58133899 | Erratum. Letter to the Editor: Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviation |
| Q36308492 | First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. |
| Q33769015 | First trimester prenatal diagnosis: fetal cells in the maternal circulation |
| Q33768998 | First trimester screening for aneuploidy: serum biochemical markers |
| Q24187589 | First trimester serum tests for Down's syndrome screening |
| Q36308489 | First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening |
| Q35736112 | First-trimester screening for aneuploidy |
| Q31142155 | Identification of expressed sequence tags preferentially expressed in human placentas by in silico subtraction |
| Q34204531 | Inhibin at 90: from discovery to clinical application, a historical review |
| Q36846529 | Inhibin, activin and follistatin in the human placenta--a new family of regulatory proteins. |
| Q38506317 | Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome |
| Q38506311 | Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome |
| Q74140538 | Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester |
| Q40902751 | Maternal serum screening for fetal genetic disorders |
| Q73444247 | Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defects |
| Q21245542 | New discoveries on the biology and detection of human chorionic gonadotropin |
| Q35574451 | Nuchal Translucency-Based Screening |
| Q35192037 | Prenatal diagnosis for detection of aneuploidy: the options |
| Q36754874 | Prenatal screening for fetal aneuploidy |
| Q33958921 | Prenatal screening for fetal aneuploidy in singleton pregnancies |
| Q37739767 | Proficiency testing of maternal serum prenatal screening in second trimester in China, 2015. |
| Q73083814 | Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection |
| Q77346175 | Regression curves for maternal serum inhibin A |
| Q74472215 | Screening for Down syndrome at 14 weeks of pregnancy |
| Q33818106 | Screening for Down's syndrome. Biochemical screening offers advantages |
| Q37125977 | Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies |
| Q77154422 | Screening for chromosomal abnormality |
| Q34356065 | Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement |
| Q22252964 | Second trimester serum tests for Down's Syndrome screening |
| Q78016981 | Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia |
| Q43064398 | Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study |
| Q71700235 | Serum markers for Down's syndrome in relation to number of previous births and maternal age |
| Q34509574 | Sonographic markers of fetal aneuploidy. |
| Q52865723 | The effect of smoking in pregnancy on maternal serum inhibin A levels. |
| Q34416763 | The prenatal diagnosis of genetic diseases |
| Q34272104 | The triple test as a screening technique for Down syndrome: reliability and relevance |
| Q33592548 | Urinary analyte screening: a noninvasive detection method for Down syndrome? |
| Q24186912 | Urine tests for Down's syndrome screening |
| Q44442310 | Using Down syndrome serum screening results to predict low birthweight |
Search more.